A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis

BACKGROUND: Long-term immunosuppression is often required in myasthenia gravis (MG). There are no published trials using methotrexate (MTX) in MG. The steroid-sparing efficacy of azathioprine (AZA) has been demonstrated after 18-months of starting therapy. However, AZA is considered expensive in Afr...

Descripción completa

Detalles Bibliográficos
Autores principales: Heckmann, Jeannine M, Rawoot, Amanullah, Bateman, Kathleen, Renison, Rudi, Badri, Motasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170595/
https://www.ncbi.nlm.nih.gov/pubmed/21819556
http://dx.doi.org/10.1186/1471-2377-11-97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170595/
https://www.ncbi.nlm.nih.gov/pubmed/21819556
http://dx.doi.org/10.1186/1471-2377-11-97

Ejemplares similares